Literature DB >> 15223248

Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.

Raija L P Lindberg1, Corline J A De Groot, Ulrich Certa, Rivka Ravid, Francine Hoffmann, Ludwig Kappos, David Leppert.   

Abstract

We used microarrays to compare the gene expression profile in active lesions and donor-matched normal appearing white matter (NAWM) from brain autopsy samples of patients with secondary progressive multiple sclerosis (MS) with that from controls who died from non-neurological diseases. The 123 genes in lesions, and 47 genes in NAWM(MS) were differentially expressed. Lesions distinguished from NAWM(MS) by a higher expression of genes related to immunoglobulin synthesis and neuroglial differentiation, while cellular immune response elements were equally dysregulated in both tissue compartments. Current results provide molecular evidence of a continuum of dysfunctional homeostasis and inflammatory changes between lesions and NAWM(MS), and support the concept of MS pathogenesis being a generalised process that involves the entire CNS.

Entities:  

Mesh:

Year:  2004        PMID: 15223248     DOI: 10.1016/j.jneuroim.2004.03.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  26 in total

Review 1.  Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain.

Authors:  Sergio E Baranzini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 2.  Genomics and proteomics: role in the management of multiple sclerosis.

Authors:  Ludwig Kappos; Lutz Achtnichts; Frank Dahlke; Jens Kuhle; Y Naegelin; Rupert Sandbrink; Raija L P Lindberg
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

Review 3.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

4.  Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.

Authors:  Mireia Guerau-de-Arellano; Yue Liu; Walter H Meisen; David Pitt; Michael K Racke; Amy E Lovett-Racke
Journal:  J Autoimmune Disord       Date:  2015

5.  Impaired neurosteroid synthesis in multiple sclerosis.

Authors:  Farshid Noorbakhsh; Kristofor K Ellestad; Ferdinand Maingat; Kenneth G Warren; May H Han; Lawrence Steinman; Glen B Baker; Christopher Power
Journal:  Brain       Date:  2011-09       Impact factor: 13.501

Review 6.  Gene expression profiling in multiple sclerosis brain.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Neurobiol Dis       Date:  2010-12-13       Impact factor: 5.996

Review 7.  Global expression profiling in epileptogenesis: does it add to the confusion?

Authors:  Yi Yuen Wang; Paul Smith; Michael Murphy; Mark Cook
Journal:  Brain Pathol       Date:  2009-02-24       Impact factor: 6.508

8.  Role of autophagy in the pathogenesis of multiple sclerosis.

Authors:  Peizhou Liang; Weidong Le
Journal:  Neurosci Bull       Date:  2015-08-08       Impact factor: 5.203

9.  Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits.

Authors:  Rosanna Pescini Gobert; Lara Joubert; Marie-Laure Curchod; Catherine Salvat; Isabelle Foucault; Catherine Jorand-Lebrun; Marc Lamarine; Hélène Peixoto; Chloé Vignaud; Christèle Frémaux; Thérèse Jomotte; Bernard Françon; Chantal Alliod; Lilia Bernasconi; Hadi Abderrahim; Dominique Perrin; Agnes Bombrun; Francisca Zanoguera; Christian Rommel; Rob Hooft van Huijsduijnen
Journal:  Mol Cell Biol       Date:  2009-01-12       Impact factor: 4.272

10.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Diane Studzinski; Ernest Retland; Bin Yao; Susan Land
Journal:  J Neuroinflammation       Date:  2009-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.